Document is current

Any future updates will be listed below

Langfristige Wirksamkeit von IL-17A-Inhibitor bei HS über 104 Wochen belegt

Crossref DOI link: https://doi.org/10.1007/s15012-025-8825-1

Published Online: 2025-07-23

Published Print: 2025-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark